These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8952264)

  • 1. [Protein- and peptide-derived radiopharmaceuticals].
    Arano Y
    Kaku Igaku; 1996 Oct; 33(10):1111-8. PubMed ID: 8952264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel radioiodination reagent for protein radiopharmaceuticals with L-lysine as a plasma-stable metabolizable linkage to liberate m-iodohippuric acid after lysosomal proteolysis.
    Wakisaka K; Arano Y; Uezono T; Akizawa H; Ono M; Kawai K; Ohomomo Y; Nakayama M; Saji H
    J Med Chem; 1997 Aug; 40(16):2643-52. PubMed ID: 9258371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of radiochemical design of antibodies using an ester bond as the metabolizable linkage: evaluation of maleimidoethyl 3-(tri-n-butylstannyl)hippurate as a radioiodination reagent of antibodies for diagnostic and therapeutic applications.
    Arano Y; Wakisaka K; Ohmono Y; Uezono T; Akizawa H; Nakayama M; Sakahara H; Tanaka C; Konishi J; Yokoyama A
    Bioconjug Chem; 1996; 7(6):628-37. PubMed ID: 8950481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the radiochemical design of antibodies with a metabolizable linkage for target-selective radioactivity delivery.
    Arano Y; Wakisaka K; Akizawa H; Ono M; Kawai K; Nakayama M; Sakahara H; Konishi J; Saji H
    Bioconjug Chem; 1998; 9(4):497-506. PubMed ID: 9667952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (67/68)Ga-labeling agent that liberates (67/68)Ga-NOTA-methionine by lysosomal proteolysis of parental low molecular weight polypeptides to reduce renal radioactivity levels.
    Uehara T; Rokugawa T; Kinoshita M; Nemoto S; Fransisco Lazaro GG; Hanaoka H; Arano Y
    Bioconjug Chem; 2014 Nov; 25(11):2038-45. PubMed ID: 25303645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of (111)In-DTPA chelate in renal radioactivity levels of (111)In-DTPA-conjugated peptides.
    Akizawa H; Arano Y; Mifune M; Iwado A; Saito Y; Uehara T; Ono M; Fujioka Y; Ogawa K; Kiso Y; Saji H
    Nucl Med Biol; 2001 May; 28(4):459-68. PubMed ID: 11395320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal metabolism of 111In-DTPA-D-Phe1-octreotide in vivo.
    Akizawa H; Arano Y; Uezono T; Ono M; Fujioka Y; Uehara T; Yokoyama A; Akaji K; Kiso Y; Koizumi M; Saji H
    Bioconjug Chem; 1998; 9(6):662-70. PubMed ID: 9815158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular metabolic fate of radioactivity after injection of technetium-99m-labeled hydrazino nicotinamide derivatized proteins.
    Ono M; Arano Y; Uehara T; Fujioka Y; Ogawa K; Namba S; Mukai T; Nakayama M; Saji H
    Bioconjug Chem; 1999; 10(3):386-94. PubMed ID: 10346868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of radioactivity after injection of liver-targeted proteins labeled with 111In or 125I. Effect of labeling on distribution and excretion of radioactivity in rats.
    Staud F; Nishikawa M; Morimoto K; Takakura Y; Hashida M
    J Pharm Sci; 1999 Jun; 88(6):577-85. PubMed ID: 10350492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evaluation of 111In-DTPAGlu-G-CCK8 for cholecystokinin-B receptor imaging.
    Aloj L; Caracò C; Panico M; Zannetti A; Del Vecchio S; Tesauro D; De Luca S; Arra C; Pedone C; Morelli G; Salvatore M
    J Nucl Med; 2004 Mar; 45(3):485-94. PubMed ID: 15001692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiolabeling in Biology.
    Zhang X; Zhang Y; Malhotra A
    Cell Biochem Biophys; 2015 May; 72(1):1-10. PubMed ID: 25413964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal uptake and metabolism of radiopharmaceuticals derived from peptides and proteins.
    Akizawa H; Uehara T; Arano Y
    Adv Drug Deliv Rev; 2008 Sep; 60(12):1319-28. PubMed ID: 18508156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
    Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
    Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical design of a radiolabeled gelatinase inhibitor peptide for the imaging of gelatinase activity in tumors.
    Hanaoka H; Mukai T; Habashita S; Asano D; Ogawa K; Kuroda Y; Akizawa H; Iida Y; Endo K; Saga T; Saji H
    Nucl Med Biol; 2007 Jul; 34(5):503-10. PubMed ID: 17591550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Instrument needs of the radiochemical processing plant.
    PARSEGIAN VL
    Nucleonics; 1950 Jan; 6(1):38-53. PubMed ID: 15398047
    [No Abstract]   [Full Text] [Related]  

  • 16. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M; Behr TM
    Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, radiolabeling and in vitro and in vivo characterization of tumor-antigen- and antibody-derived peptides for the detection of breast cancer.
    Okarvi SM; Jammaz IA
    Anticancer Res; 2009 Apr; 29(4):1399-409. PubMed ID: 19414394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical design of radiolabeled antibody fragments for low renal radioactivity levels.
    Arano Y; Fujioka Y; Akizawa H; Ono M; Uehara T; Wakisaka K; Nakayama M; Sakahara H; Konishi J; Saji H
    Cancer Res; 1999 Jan; 59(1):128-34. PubMed ID: 9892197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vivo disposition and in vitro transmembrane transport of two model radiometabolites of DOTA-conjugated receptor-specific peptides labelled with (177) Lu.
    Volková M; Mandíková J; Bárta P; Navrátilová L; Lázníčková A; Trejtnar F
    J Labelled Comp Radiopharm; 2015; 58(13-14):483-9. PubMed ID: 26526343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel, self-shielded modular radiosynthesis system for fully automated preparation of PET and therapeutic radiopharmaceuticals.
    Kroselj M; Socan A; Zaletel K; Dreger T; Knopp R; Gmeiner T; Kolenc Peitl P
    Nucl Med Commun; 2016 Feb; 37(2):207-14. PubMed ID: 26443981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.